AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions

[1]  Jason D. Wright,et al.  Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Ohrbach,et al.  Approaches to Demonstrating the Reliability and Validity of Core Diagnostic Criteria for Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[3]  R. Dworkin,et al.  Multidimensional Diagnostic Criteria for Chronic Pain: Introduction to the ACTTION-American Pain Society Pain Taxonomy (AAPT). , 2016, The journal of pain : official journal of the American Pain Society.

[4]  R. Dworkin,et al.  The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[5]  R. Ohrbach,et al.  Assessment of Psychosocial and Functional Impact of Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[6]  David A. Williams,et al.  Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification. , 2016, The journal of pain : official journal of the American Pain Society.

[7]  T. Jensen,et al.  Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel , 2016, Pain.

[8]  A. Benson,et al.  Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies. , 2016, Clinical colorectal cancer.

[9]  A. Saykin,et al.  Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Jonathan G. Lees,et al.  The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy , 2016, Pain.

[11]  H. Friess,et al.  Neural plasticity in pancreatitis and pancreatic cancer , 2015, Nature Reviews Gastroenterology &Hepatology.

[12]  Ryan M. Cassidy,et al.  MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy , 2015, Brain, Behavior, and Immunity.

[13]  S. Flatters,et al.  Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy , 2015, The journal of pain : official journal of the American Pain Society.

[14]  Ryan M. Cassidy,et al.  The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4 , 2015, The Journal of Neuroscience.

[15]  P. Meltzer,et al.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Vanderah,et al.  Use of Animal Models in Understanding Cancer-induced Bone Pain , 2015, Cancer growth and metastasis.

[17]  C. Loprinzi,et al.  Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study. , 2015, Journal of pain and symptom management.

[18]  S. C. Adams,et al.  Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study , 2015, BMC Cancer.

[19]  B. Schmidt,et al.  TMPRSS2, a novel membrane-anchored mediator in cancer pain , 2015, Pain.

[20]  B. Schmidt.  What pain tells us about cancer. , 2015, Pain.

[21]  Blair H. Smith,et al.  A classification of chronic pain for ICD-11 , 2015, Pain.

[22]  D. McLeod,et al.  PTHrP-mediated hypercalcemia: causes and survival in 138 patients. , 2015, The Journal of clinical endocrinology and metabolism.

[23]  P. Mantyh,et al.  NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use. , 2014, Cancer research.

[24]  P. Mantyh,et al.  Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain , 2014, PAIN®.

[25]  Gillian L. Currie,et al.  Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis , 2014, PAIN®.

[26]  C. Cleeland,et al.  A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. , 2014, Cancer research.

[27]  H. Sørensen,et al.  Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. , 2014, Lung cancer.

[28]  S. Shete,et al.  Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. , 2014, The journal of pain : official journal of the American Pain Society.

[29]  T. Taverner.  Neuropathic pain in people with cancer (part 1): incidence, manifestation, and assessment. , 2014, International journal of palliative nursing.

[30]  W. Boogerd,et al.  Chemotherapy-induced neuropathy: A comprehensive survey. , 2014, Cancer treatment reviews.

[31]  Kathryn A. Lee,et al.  Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy , 2014, Cancer.

[32]  A. Zedan,et al.  Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires. , 2014, Basic & clinical pharmacology & toxicology.

[33]  Saranya Chumsri,et al.  Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience , 2014, SpringerPlus.

[34]  Dawn L Hershman,et al.  Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  P. Mantyh.  Bone cancer pain: from mechanism to therapy , 2014, Current opinion in supportive and palliative care.

[36]  A. Dickenson,et al.  Pain and nociception: mechanisms of cancer-induced bone pain. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  A. Miah,et al.  Nonsurgical oncological management of cancer pain , 2014, Current opinion in supportive and palliative care.

[38]  Y. T. Cheung,et al.  Management options for established chemotherapy-induced peripheral neuropathy , 2014, Supportive Care in Cancer.

[39]  L. Wu,et al.  The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. , 2014, Current oncology.

[40]  R. Massey,et al.  Brief review: Chemotherapy-induced painful peripheral neuropathy (CIPPN): current status and future directions , 2014, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[41]  Roman Rolke,et al.  Confirming neuropathic pain in cancer patients: Applying the NeuPSIG grading system in clinical practice and clinical research , 2014, PAIN®.

[42]  B. Schmidt.  The Neurobiology of Cancer Pain , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[43]  R. Baron,et al.  Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria , 2014, Current medical research and opinion.

[44]  Thomas J. Smith,et al.  The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions. , 2014, The journal of pain : official journal of the American Pain Society.

[45]  N. Zhang,et al.  Spinal Changes of a Newly Isolated Neuropeptide Endomorphin-2 Concomitant with Vincristine-Induced Allodynia , 2014, PloS one.

[46]  R. Freeman,et al.  Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs , 2014, PAIN®.

[47]  Y. Ishida,et al.  Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies , 2014, Anesthesiology.

[48]  M. Bennett,et al.  Practical Management of Complex Cancer Pain , 2014 .

[49]  Maree T. Smith,et al.  Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN) , 2013, Front. Pharmacol..

[50]  R. Umbas,et al.  Anxiety level of early- and late-stage prostate cancer patients , 2013, Prostate international.

[51]  P. Mantyh.  Bone cancer pain: Causes, consequences, and therapeutic opportunities , 2013, PAIN®.

[52]  R. Treede,et al.  Pain in chemotherapy-induced neuropathy – More than neuropathic? , 2013, PAIN®.

[53]  J. Snowden,et al.  Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. , 2013, Journal of pain and symptom management.

[54]  M. Koltzenburg,et al.  Chemotherapy‐induced peripheral neurotoxicity: A critical analysis , 2013, CA: a cancer journal for clinicians.

[55]  A. Pokryszko-Dragan,et al.  Bortezomib-induced painful neuropathy in patients with multiple myeloma , 2013, Contemporary oncology.

[56]  Ripamonti Carla,et al.  Prevention and Treatment of Bone Metastases in Breast Cancer , 2013, Journal of clinical medicine.

[57]  C. Farrell.  Bone metastases: assessment, management and treatment options. , 2013, British journal of nursing.

[58]  L. Carey,et al.  CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  Kecheng Xu,et al.  Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block. , 2013, Cryobiology.

[60]  C. Cleeland,et al.  Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy , 2013, Cancer Chemotherapy and Pharmacology.

[61]  P. Dougherty,et al.  Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine , 2013, Cancer Chemotherapy and Pharmacology.

[62]  Liying Zhang,et al.  Minimal clinically important differences in the brief pain inventory in patients with bone metastases , 2013, Supportive Care in Cancer.

[63]  G. Altavilla,et al.  The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[64]  D. Pud,et al.  Chemotherapy‐Induced Neuropathic Pain and Its Relation to Cluster Symptoms in Breast Cancer Patients Treated with Paclitaxel , 2013, Pain practice : the official journal of World Institute of Pain.

[65]  H. Kehlet,et al.  Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide , 2012, Acta oncologica.

[66]  Dong-Wan Kim,et al.  Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. , 2012, Lung cancer.

[67]  C. Cleeland,et al.  Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. , 2012, The journal of pain : official journal of the American Pain Society.

[68]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[69]  M. Stubblefield,et al.  A prospective surveillance model for physical rehabilitation of women with breast cancer , 2012, Cancer.

[70]  C. Cleeland,et al.  Subclinical Peripheral Neuropathy Is a Common Finding in Colorectal Cancer Patients Prior to Chemotherapy , 2012, Clinical Cancer Research.

[71]  C. V. D. van de Velde,et al.  Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study. , 2012, The Lancet. Oncology.

[72]  Guido Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. , 2012, Critical reviews in oncology/hematology.

[73]  S. Buga,et al.  The management of pain in metastatic bone disease. , 2012, Cancer control : journal of the Moffitt Cancer Center.

[74]  Liying Zhang,et al.  Symptom clusters in patients with bone metastases—a reanalysis comparing different statistical methods , 2012, Supportive Care in Cancer.

[75]  M. Koltzenburg,et al.  Normal pressure hydrocephalus: how often does the diagnosis hold water? , 2012, Neurology.

[76]  B. Laird,et al.  Quantitative Sensory Testing to assess the sensory characteristics of cancer‐induced bone pain after radiotherapy and potential clinical biomarkers of response , 2012, European journal of pain.

[77]  G. Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. , 2011, The Lancet. Oncology.

[78]  M. Rodionova,et al.  Clinical symptoms of bone marrow metastases in breast cancer patients , 2011 .

[79]  G. Hostetter,et al.  Perineural invasion and associated pain in pancreatic cancer , 2011, Nature Reviews Cancer.

[80]  P. Dougherty,et al.  Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients. , 2011, The journal of pain : official journal of the American Pain Society.

[81]  Gordon D. Murray,et al.  Characterization of cancer-induced bone pain: an exploratory study , 2011, Supportive Care in Cancer.

[82]  Yelena Granovsky,et al.  Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy. , 2011, Journal of pain and symptom management.

[83]  R. Portenoy.  Treatment of cancer pain , 2011, The Lancet.

[84]  D. Esseltine,et al.  Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. , 2011, The Lancet. Oncology.

[85]  D. Tripathy,et al.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain. , 2011, The journal of pain : official journal of the American Pain Society.

[86]  S. Carrara,et al.  Celiac plexus block for pancreatic cancer pain in adults. , 2011, The Cochrane database of systematic reviews.

[87]  P. Farquhar-smith.  Chemotherapy-induced neuropathic pain , 2011, Current opinion in supportive and palliative care.

[88]  J. Paice.  Chronic treatment-related pain in cancer survivors , 2011, PAIN.

[89]  E. Philip,et al.  Psychological distress in patients with pancreatic cancer—an understudied group , 2010, Psycho-oncology.

[90]  G. Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity , 2010, Nature Reviews Neurology.

[91]  A. Jakubowiak,et al.  Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies , 2010, Leukemia & lymphoma.

[92]  J. Farrar,et al.  Assessment of cancer-related neuropathy and neuropathic pain. , 2010, The oncologist.

[93]  K. Anderson,et al.  Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[94]  A. Sahgal,et al.  Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index. , 2010, Journal of pain and symptom management.

[95]  G. Cavaletti,et al.  Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools. , 2010, European journal of cancer.

[96]  Jeff Myers,et al.  Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting , 2010, Supportive Care in Cancer.

[97]  K. Nemoto,et al.  Time Course of Pain Relief in Patients Treated With Radiotherapy for Cancer Pain: A Prospective Study , 2010, The Clinical journal of pain.

[98]  R. Koul,et al.  Bone Metastasis – an overview , 2009 .

[99]  J. Cuzick,et al.  Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  F. De Conno,et al.  Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[101]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.

[102]  Z. Lidar,et al.  Surgical management of metastatic bone disease. , 2009, The Journal of bone and joint surgery. American volume.

[103]  M. Fallon,et al.  Translational medicine: cancer pain mechanisms and management. , 2008, British journal of anaesthesia.

[104]  G. La Torre,et al.  Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features. , 2008, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[105]  Susan Halabi,et al.  Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  M. Malawer,et al.  Metastatic carcinoma of the long bones. , 2007, American family physician.

[107]  A. Caraceni,et al.  The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity Scale , 2007, Journal of the peripheral nervous system : JPNS.

[108]  T. Guise,et al.  Cancer-associated bone disease , 2007, Current osteoporosis reports.

[109]  B. Davis,et al.  Pain in chronic pancreatitis and pancreatic cancer. , 2007, Gastroenterology clinics of North America.

[110]  P. Dougherty,et al.  Quantitative sensory findings in patients with bortezomib-induced pain. , 2007, The journal of pain : official journal of the American Pain Society.

[111]  A. Dickenson,et al.  Central neuronal mechanisms in cancer-induced bone pain , 2007, Current opinion in supportive and palliative care.

[112]  J. Gralow,et al.  Managing metastatic bone pain: the role of bisphosphonates. , 2007, Journal of pain and symptom management.

[113]  E. Chow,et al.  Symptom clusters in cancer patients with bone metastases , 2007, Supportive Care in Cancer.

[114]  P. Ghezzi,et al.  Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth. , 2007, European journal of cancer.

[115]  P. Dougherty,et al.  Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. , 2007, Journal of pain and symptom management.

[116]  N. Pouratian,et al.  Part II: spinal-cord neoplasms--primary tumours of the bony spine and adjacent soft tissues. , 2007, The Lancet. Oncology.

[117]  R. Coleman.  Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[118]  G. Hruby,et al.  Mild, moderate, or severe pain categorized by patients with cancer with bone metastases. , 2006, Journal of palliative medicine.

[119]  G. Dranitsaris,et al.  Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer. , 2006, The oncologist.

[120]  F. Lieberman,et al.  Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. , 2006, Seminars in oncology.

[121]  Linqiu Zhou,et al.  Pharmacologic Management of Cancer Pain , 2005, The Journal of the American Osteopathic Association.

[122]  S. Paul,et al.  Predictors of quality of life in oncology outpatients with pain from bone metastasis. , 2005, Journal of pain and symptom management.

[123]  M. Stillman,et al.  Chemotherapy-induced peripheral neuropathy. , 2005, Oncology nursing forum.

[124]  M. Lam,et al.  186Re-HEDP for metastatic bone pain in breast cancer patients , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[125]  Alison P. Klein,et al.  Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.

[126]  R. Wong,et al.  Quality of life after local external beam radiation therapy for symptomatic bone metastases: a prospective evaluation. , 2004, Supportive cancer therapy.

[127]  S. Mercadante,et al.  Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. , 2003, Journal of pain and symptom management.

[128]  C. Herndon.  Pharmacologic Management of Cancer Pain , 2003, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[129]  A. Lissoni,et al.  Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale , 2003, Neurology.

[130]  E. Cheng.  Prospective quality of life research in bony metastatic disease. , 2003, Clinical orthopaedics and related research.

[131]  Bagi Cm.  Skeletal implications of prostate cancer. , 2003 .

[132]  H. Satoh,et al.  BONE METASTASIS AS THE FIRST MANIFESTATION OF LUNG CANCER , 2003, International journal of clinical practice.

[133]  A. Caraceni,et al.  Classification of cancer pain syndromes. , 2001, Oncology.

[134]  A. Caraceni.  Evaluation and assessment of cancer pain and cancer pain treatment , 2001, Acta anaesthesiologica Scandinavica.

[135]  R. Coleman.  Metastatic bone disease: clinical features, pathophysiology and treatment strategies. , 2001, Cancer treatment reviews.

[136]  R. Cook,et al.  Methodology for treatment evaluation in patients with cancer metastatic to bone. , 2001, Journal of the National Cancer Institute.

[137]  J. Cameron,et al.  Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[138]  A. Aboulafia,et al.  Incidence, location, and diagnostic evaluation of metastatic bone disease. , 2000, The Orthopedic clinics of North America.

[139]  J. Rykowski,et al.  Efficacy of Neurolytic Celiac Plexus Block in Varying Locations of Pancreatic Cancer: Influence on Pain Relief , 2000, Anesthesiology.

[140]  A. Caraceni,et al.  An international survey of cancer pain characteristics and syndromes , 1999, PAIN.

[141]  K. Lillemoe,et al.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer , 1999, British Journal of Cancer.

[142]  J. Bucholtz.  Metastatic epidural spinal cord compression. , 1999, Seminars in oncology nursing.

[143]  H. Libshitz,et al.  Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. , 1998, Journal of pain and symptom management.

[144]  Brant Jm.  Cancer-related neuropathic pain. , 1998, Nurse practitioner forum.

[145]  S. Yoneda,et al.  [Bone metastasis of primary lung cancer]. , 1998, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[146]  Lisa L. Phillips.  Managing the pain of bone metastases in the home environment , 1998, The American journal of hospice & palliative care.

[147]  A. Caraceni,et al.  Pain management in patients with pancreatic carcinoma , 1996, Cancer.

[148]  D. Walsh,et al.  Symptoms of pancreatic cancer. , 1991, Journal of pain and symptom management.

[149]  R. Portenoy,et al.  Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.

[150]  T. Powles,et al.  Assessment of response of bone metastases to systemic treatment in patients with breast cancer , 1983, Cancer.

[151]  J. Schmidt,et al.  Bone pain in metastatic cancer of prostate. , 1979, Urology.

[152]  Victor Barley,et al.  Treatment of Cancer , 1908, Nature.

[153]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[154]  C. Woolf,et al.  Towards a mechanism-based approach to pain diagnosis , 2016 .

[155]  S. Flatters.  The contribution of mitochondria to sensory processing and pain. , 2015, Progress in molecular biology and translational science.

[156]  T. Postma,et al.  Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[157]  B. Laird,et al.  A characterization study of breakthrough pain in cancer-induced bone pain , 2012 .

[158]  黒坂 眞二.  EORTC QLQ-BM22 and QLQ-C30 quality-of-life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy , 2012 .

[159]  R. Pignataro,et al.  Chemotherapy Induced Peripheral Neuropathy: Risk Factors, Pathophysiology, Assessment, and Potential Physical Therapy Interventions , 2010 .

[160]  K. Wilson,et al.  Prevalence and correlates of pain in the Canadian National Palliative Care Survey. , 2009, Pain research & management.

[161]  M. Tsao,et al.  Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. , 2009, Journal of pain and symptom management.

[162]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.

[163]  Matthew P. Goetz,et al.  Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem , 2005, Skeletal Radiology.

[164]  C. Bagi.  Skeletal implications of prostate cancer. , 2003, Journal of musculoskeletal & neuronal interactions.

[165]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.